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apid development of information technologies in 
the past two decades has brought about major im-
provements in the generation, sharing and analysis 
of information on the health status of the entire human 
population. This has facilitated the development of the field 
of “Global Health Metrics”, which has its champions in 
World Health Organization's Mortality and Burden of Dis-
ease Unit and University of Washington’s Institute for 
Health Metrics and Evaluation (IHME). A number of other 
groups, initiatives and institutions also contribute substan-
tially to this field and regularly publish population health 
estimates. These include national epidemiological services, 
population–specific (eg, occupational, ethnic, age–and 
gender–defined) and disease–specific registries, academic 
research groups interested in specific health problems, pro-
Assembling GHERG: 
Could “academic crowd–
sourcing” address gaps in 
global health estimates?
Igor Rudan1, Harry Campbell1, Ana Marušic´1,2,3, Devi Sridhar1, Harish Nair1, 
Davies Adeloye1, Evropi Theodoratou1, Kit Yee Chan1
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and PLoS Medicine journals worked together to improve reporting of population health estimates. The 
new guidelines for accurate and transparent health estimates reporting (likely to be named GATHER), 
which are eagerly awaited, represent a helpful move that should benefit the field of global health metrics. 
Building on this progress and drawing from a tradition of Child Health Epidemiology Reference Group 
(CHERG)’s successful work model, we would like to propose a new initiative – “Global Health Epidemi-
ology Reference Group” (GHERG). We see GHERG as an informal and entirely voluntary international col-
laboration of academic groups who are willing to contribute to improving disease burden estimates and 
respect the principles of the new guidelines – a form of “academic crowd–sourcing”. The main focus of 
GHERG will be to identify the “gap areas” where not much information is available and/or where there is 
a lot of uncertainty present about the accuracy of the existing estimates. This approach should serve to 
complement the existing WHO and IHME estimates and to represent added value to both efforts.
fessional societies that specialize in a particular disease(s), 
and initiatives by international organizations.
Examples of organizations specializing in population health 
surveillance that require health metrics as a starting point 
include the United States Centers for Disease Control and 
Prevention (USCDCP), European Centre for Disease Pre-
vention and Control (ECDPC), Chinese Center for Disease 
Control and Prevention (CCDCP), International Agency for 
Research on Cancer (IARC) and the United Nation’s Chil-
dren Fund (UNICEF). All of these organizations regularly 
publish summaries of large amounts of information on 
population health that is collected through their services. 
Moreover, the Demographic and Health Surveys (DHS) 
Program, supported by USAID, continues to collect, ana-
lyze and disseminate representative data on population, 
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health, HIV, and nutrition through more than 300 nation-
ally–representative household surveys in over 90 countries. 
Similarly, UNICEF assists countries in collecting and ana-
lyzing data on health of women and children through its 
household survey program called Multiple Indicator Clus-
ter Surveys (MICS).
Further to these efforts, professional societies such as the 
International Diabetes Federation (IDF) and Alzheimer 
Disease International (ADI) work together with the World 
Health Organization to develop and regularly update the 
global, regional, and sometimes national estimates of type 
2 diabetes and dementia, respectively. There are many oth-
er examples of successful collaborations between interna-
tional agencies and academic research groups in order to 
develop accurate and transparent population health esti-
mates. Some of the most notable examples are the United 
Nation’s Inter–Agency Group for Child Mortality Estima-
tion (IGME), and the Child Health Epidemiology Reference 
Group (CHERG), in which our group in Edinburgh has 
also been involved for the past decade. IGME regularly re-
vises the overall child mortality estimates at the national 
level, while CHERG made major contributions to the un-
derstanding of the leading causes of child deaths globally, 
regionally and nationally. CHERG’s work provided much 
needed evidence to inform and help direct policies towards 
achieving UN’s Millennium Development Goal 4. CHERG 
developed into a collaboration between the WHO, UNI-
CEF and a group of independent technical experts from 
leading academic institutions who worked together to as-
semble available information on the causes of child deaths 
in parts of the world where there was no adequate vital reg-
istration coverage. An important aspect of CHERG work 
was to critically review this information and to include only 
data which met stated quality criteria regarding validity and 
representativeness.
In addition to understanding the burden of disease in hu-
man populations, determinants of the burden – ie, the un-
derlying risk factor causes that make people ill – are also 
of interest to the field of global health metrics. Several 
countries or regions have set up large–scale biobanks in re-
cent years to study determinants of population health on a 
very large scale, using a “big data” approach. Some of the 
most impressive examples are UK Biobank, the Kadoorie 
biobank in China, and the EPIC prospective study in Eu-
rope. Each one of these biobanks includes about 500 000 
persons which should give them sufficient study power to 
tease out the effects of many different potential environ-
mental, genetic and lifestyle contributors to human diseas-
es. Likewise, there are academic groups that regularly re-
view and assess the scientific literature to identify risk 
factors through large meta–analyses, such as the INTER-
HEART Study which evaluates risk factors for myocardial 
infarction (MI), or Environment and Global Health Re-
search Group at the Imperial College London, which col-
laborates with the WHO to provide national–level updates 
on risk factors such as the prevalence of obesity, hypercho-
lesterolemia, hypertension and hyperglycaemia.
The “big data” approach to global health metrics, currently 
championed by IHME and increasingly adopted by other 
groups, should work well over time. The application of so-
phisticated analytical methods to these massive data sets 
should be expected to yield population health estimates 
that would continuously improve over time. However, 
there are also problems with reliance on “big data” and the 
field of global health metrics is particularly prone to some 
of the most frequently highlighted concerns [1]. The much 
larger amount of data under study will not necessarily 
make the estimates of disease burden more accurate if most 
of the data are systematically biased. Moreover, there is a 
false assumption that very large amount of data automati-
cally implies that the collection will cover all parts of the 
world adequately and represent underlying populations 
well. Unfortunately, the global health data available in the 
public domain today suffers from both these problems. De-
spite the increasing availability of massive data sets of pop-
ulation–based data the field of global health metrics still 
faces a number of important challenges.
First, a lot of population health data that is readily available 
in the public domain, or to organizations such as the WHO 
or IHME, are national–level estimates based on reporting 
to national epidemiological services. There is a possibility 
that these estimates suffer from systematic under–report-
ing, resulting in estimates that are much lower than the ac-
tual situation, even although they are based on very large 
amounts of data. Second, although the current global 
health estimates by both WHO and IHME for 2013 make 
a laudable attempt to model the estimates at the national 
level for each country in the world, this gives a false im-
pression that there is relevant information available from 
all these countries. In reality, there are some parts of the 
world in which there is an abundance of information and 
the estimates are very precise. However, there are also oth-
er regions, and also certain diseases and risk factors, for 
which the amount of information is remarkably scarce. For 
some of these countries (or sub–national areas) and condi-
tions the situation has not improved over the past 20–30 
years, leading to very large degrees of uncertainty in disease 
burden estimates. The investment in and development of 
ever more sophisticated methods of computation and/or 
epidemiological modeling is less important to achieving 
valid disease burden estimates – which reflect the true bur-
den in the world population – than investment in generat-
ing a sufficient amount of reliable information in those 
countries and conditions.
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These inherent uncertainties are further compounded by 
the lack of complete transparency from the IHME over their 
input data that could allow other investigators to replicate 
their computations and assess the true amount of uncer-
tainty in many of their estimates. In fairness to IHME, 
though, very few researchers outside the field of global 
health metrics can truly comprehend the scale of their ef-
fort and the size of their data sets, so it is perhaps not sur-
prising that they may feel that they need to continue to re-
fine their data sets and methods through further iterations 
before they are ready to fully expose them to the rest of the 
global health research community. [2] However, as long as 
they do not open their input data and all their methods to 
a full independent replication by other legitimate academ-
ic groups, who do understand these issues – and there are 
several groups that could do this – it will continue to be 
difficult for the global health community to fully accept 
IHME’s estimates. Consistent replication of any scientifi-
cally produced result by independent research groups has 
been a norm in other fields of science, making the key dif-
ference between an initial report and a broadly accepted 
new knowledge. In the end, IHME should benefit more 
than any other parties from opening their work to other 
groups – from getting an independent review and feedback 
on their work, to gaining scientific legitimacy and obtain-
ing suggestions on where to focus further efforts to con-
tinue improving their estimates.
In recent months, the WHO and IHME have started to 
work together with a group of independent academic re-
searchers from this field and senior staff from the Lancet 
and PLoS Medicine journals to improve the reporting of 
population health estimates and, through this, improve the 
accuracy and transparency of estimates. The new guide-
lines – likely to be named GATHER (which would stand as 
an acronym for the “Guidelines for Accurate and Transpar-
ent Health Estimates Reporting”) – should improve prac-
tices of both those who generate and report primary infor-
mation on health estimates and those who assemble the 
primary information and model it to develop global, re-
gional and national health estimates for diseases and risk 
factors. Once adopted fully, the new reporting guidelines 
will represent a very helpful step forward that should ben-
efit the field. Successful collaboration of the WHO and 
IHME teams and international academic experts (including 
from our Centre for Global Health Research in Edinburgh) 
on finalizing these guidelines would be a very welcome de-
velopment, especially if adherence to such guidelines be-
comes a requirement for publication in all the leading med-
ical journals [3].
We may conclude that, at this point, many positive devel-
opments are occurring in the field of global health metrics. 
The introduction of “big data” approaches, the develop-
ment of more sophisticated and improved analytic meth-
ods, and improved use of new information technologies for 
data storage and visualization are all contributing to prog-
ress. The introduction of new guidelines should add to this 
progress and generate more papers with primary health 
data that would be of sufficient reporting quality to be use-
ful for inclusion in different epidemiological models. They 
will also help to clarify which input data are being used in 
the models and how the models work.
However, as noted above, there is also a need to increas-
ingly focus on how to generate a lot more information on 
disease burden and risk factors from “gap” areas of the 
world. This is particularly true for diseases and risks on 
which there is hardly any data or epidemiological research 
in recent decades, and where none of these elements of 
progress will be able to lead to trustworthy estimates. Pos-
sible approaches to address these gaps will need to include 
research capacity building in gap countries and regions in 
conducting and reporting epidemiological research. A net-
work of international medical journals interested in global 
health – such as our Journal of Global Health – could play a 
substantial role in this capacity building. There is a need to 
educate both the researchers and the journal editors in less 
developed regions of the good practices and adherence to 
new guidelines in reporting their health estimates. It is pos-
sible that new technologies – such as mHealth and eHealth, 
ie, the use of mobile phones and internet to gather infor-
mation – may also enable forms of “crowd–sourcing” ap-
proaches to generate population health data in the areas of 
the world where no other approaches can guarantee suc-
cess and to understand burden of health problems in real 
time.
In recent years, our Edinburgh–based group has “special-
ized” in finding useful health information and developing 
population health estimates for epidemiologically under–
researched problems and areas [4]. This led to the award 
of the status of the World Health Organization’s Collabo-
rating Centre for Population Research and Training. Our 
“gap–filling” efforts include trying to learn more about the 
emerging and alternative sources of medical literature and 
health information, such as recently digitalized Chinese 
medical databases CNKI, WanFang, VIP and others. This 
led to much improved estimates for several major health 
issues in transitioning China, such as a dramatic reduction 
of child mortality and its likely causes [5,6], a much finer 
resolution of the causes of mortality from childhood acci-
dents [7], or the first comprehensive estimates of the bur-
den of dementia [8] and schizophrenia [9] among the adult 
and elderly Chinese population. For the African continent, 
we have provided estimates of dementia, COPD, epilepsy, 
colorectal cancer and rheumatoid arthritis. Likewise, for 
South Asia, we have published estimates for type 2 diabe-
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tes [10–14]. In this current journal issue, we are also pub-
lishing a study that estimated of the burden of rheumatoid 
arthritis in LMICs that was largely based on information 
from non–English databases and the so–called ‘grey litera-
ture’ [15]. We used similar approaches to develop global, 
regional and, national (wherever allowed by data) estimates 
for rather neglected and under–researched problems in 
global health such as childhood pneumonia [16,17], pe-
ripheral arterial disease [18] and sequelae from childhood 
meningitis [19].
Perhaps even more relevant to this “gap–filling” agenda, 
our group in Edinburgh also pioneered the approach of 
“academic crowd–sourcing” to address some health issues 
of specific interest, for which remarkably few data are avail-
able in the public domain. As an example, in our attempts 
to estimate the global, regional and national burden of RSV 
and influenza infections in children – both of which are 
important because of a possible opportunities for immuni-
zation – we gathered a group of well–minded independent 
experts who were in possession of either published or un-
published useful information on these under–researched 
topic, and who agreed to share these data for the purposes 
of developing global, regional and national estimates [20–
22]. Through this approach, we have found out that there 
is much more useful information available than could be 
concluded based on reviews of published sources. How-
ever, many of the most useful data sets were from studies 
established for other purposes such as data from control 
arms of randomized controlled trials which have a disease 
of interest as an outcome, or data from surveillance systems 
such as that set up to monitor the evolution of influenza 
and act as an alert mechanism for viruses with pandemic 
potential. Mobilizing these valuable sources of data have 
greatly improved that information available to burden of 
disease models compared to what was available solely 
through publically available sources [20–22].
This is precisely where we would like to position a new ini-
tiative – the “Global Health Epidemiology Reference Group” 
(GHERG). We would like to propose an informal and en-
tirely voluntary international collaboration of academic 
groups willing to contribute to improving disease burden 
estimates to complement IHME activities and who agree to 
respect the principles of the new guidelines – a form of “ac-
ademic crowd–sourcing”. Most importantly, all the input 
data, methods and work should be fully transparent and ac-
cessible to all other qualified researchers to verify and repli-
cate them. Ideally, all GHERG papers should have more than 
one research group involved, and all of the collaborating 
groups would need to have full access to data. GHERG 
should, therefore, become an extension of Child Health Ep-
idemiology Reference Group (CHERG), aiming to address 
global health issues in age groups beyond 0–4 years.
The overall goal of GHERG will be to develop and deploy 
new and improved evidence on the causes and determi-
nants of morbidity and mortality among populations in all 
world regions, on the importance of a broad range of risk 
factors, and on the effectiveness of public health interven-
tions, to inform and influence global priorities and pro-
grams. The main focus will continue to be on identifying 
the “gap areas” where not much information is available 
and where there is a lot of uncertainty present about the 
accuracy of the existing estimates. This approach should 
serve to complement the existing WHO and IHME esti-
mates and to represent added value to both efforts.
The main purposes of the GHERG will be to publish papers, 
reports and reviews on global health epidemiology, with a 
special focus on identifying information of sufficient quality 
in low and middle–income countries and filling the gaps in 
information for regions where the data are very scarce and 
of insufficient quality. Also, we would like to advise WHO 
and other international organizations, institutions and initia-
tives on the most appropriate methods and assumptions for 
their global, regional and country level epidemiological es-
timates. We will aim to advise researchers and public health 
officials on the different issues involved in the estimation of 
cause–specific morbidity and mortality.
The core membership of GHERG will initially be offered to 
the editors and regional editors of the Journal of Global 
Health, who are all independent researchers working for 
the leading academic institutions. However, GHERG will 
be open to literally everyone to contribute their data, meth-
ods and estimates. It will aim to serve global health com-
munity by providing unrestricted open access to its data 
sets, methods and publications, and continuously revising 
and updating global health estimates for a targeted set of 
conditions.
Accurate global health estimates are extremely important 
because they expose the key issues, inform health policies, 
direct funding disbursements and eventually solve prob-
lems and save lives. In that sense, they could be viewed as 
a “matter of life and death”. Because of this, when it comes 
to global health estimates, we see value in both collabora-
tion and competition. Two, three or even more estimates 
of the same problem, generated by independent research 
groups, are certainly more informative and helpful than 
only one – especially if all of them are fully transparent and 
their methods can be compared [2]. If the principles of the 
new guidelines are respected by all research groups in the 
field, then all different estimates would eventually be ex-
pected to converge to the same, reliable set of estimates that 
we are hoping to deliver to the global health community 
for their unrestricted use.
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